🇺🇸 Luvox CR in United States

105 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 105

Most-reported reactions

1. Insomnia — 14 reports (13.33%)
2. Weight Increased — 13 reports (12.38%)
3. Anxiety — 12 reports (11.43%)
4. Drug Ineffective — 12 reports (11.43%)
5. Somnolence — 12 reports (11.43%)
6. Fatigue — 10 reports (9.52%)
7. Depression — 9 reports (8.57%)
8. Abdominal Pain Upper — 8 reports (7.62%)
9. Nausea — 8 reports (7.62%)
10. Dyspnoea — 7 reports (6.67%)

Source database →

Frequently asked questions

Is Luvox CR approved in United States?

Luvox CR does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Luvox CR in United States?

Rogers Center for Research & Training, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.